trial

Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode

NCTId NCT02823041
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 100 (estimated)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2023-06-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
100 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2016-10-13
Primary completion
2023-06-30
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
Cognitive trainingAerobic exerciseCase management and supportive psychotherapyIndividual Placement and Support

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor

Investigators

1
Keith H Nuechterlein, Ph.D.Principal Investigator

Sites

1 total
Los Angeles, United States

Facts & assertions

4 sourced
Enrollment
100
Phase
NA
Primary Completion Date
2023-06-30
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive training
drug
Aerobic exercise
drug
Case management and supportive psychotherapy
drug
Individual Placement and Support
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
indication
Schizophreniform Disorder
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
investigator
Keith H Nuechterlein, Ph.D.
person